Pivekimab, also IBAT®, is the innovative synthesized targeted protein developed with specifically interact with or inhibit IL-6, a critical inflammatory mediator associated to multiple pathogenic responses driving chronic illnesses. This experimental molecule appears to be generated via cell gene… Read More

MORAb-003, this therapeutic, the antibody is, represents, signifies a novel, innovative, promising agent, treatment, approach targeting MUC1, this protein, the mucin expressed, overexpressed, found on tumor, cancerous, malignant cells, tissues, growths. Researchers, Scientists, Investigators beli… Read More